 EON: Enhanced Online News (press release) | Biogen Idec and Abbott Present Positive Data for Daclizumab HYP from Select ... EON: Enhanced Online News (press release) The SELECT data was presented in a late-breaking platform presentation, called A randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of daclizumab HYP monotherapy in relapsing-remitting multiple sclerosis: primary ... |
